<http://schema.org/description>
"Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool&amp;#039;s free investing community, biotechnology company Hyperion Therapeutics  has"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2013/01/18/why-hyperion-is-poised-to-pull-back/20433357/?gen=1>